div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page1jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails1jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page2jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails2jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page3jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails3jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page4jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails4jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page5jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails5jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page6jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails6jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=7Page 7button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page7jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=7 data-page=7 class=ts-thumb lazyload alt=Page 7: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails7jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=8Page 8button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page8jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=8 data-page=8 class=ts-thumb lazyload alt=Page 8: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails8jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=9Page 9button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page9jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=9 data-page=9 class=ts-thumb lazyload alt=Page 9: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails9jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=10Page 10button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page10jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=10 data-page=10 class=ts-thumb lazyload alt=Page 10: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails10jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=11Page 11button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page11jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=11 data-page=11 class=ts-thumb lazyload alt=Page 11: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails11jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=12Page 12button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page12jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=12 data-page=12 class=ts-thumb lazyload alt=Page 12: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails12jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=13Page 13button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page13jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=13 data-page=13 class=ts-thumb lazyload alt=Page 13: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails13jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=14Page 14button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page14jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=14 data-page=14 class=ts-thumb lazyload alt=Page 14: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails14jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=15Page 15button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page15jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=15 data-page=15 class=ts-thumb lazyload alt=Page 15: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails15jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=16Page 16button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page16jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=16 data-page=16 class=ts-thumb lazyload alt=Page 16: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails16jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=17Page 17button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page17jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=17 data-page=17 class=ts-thumb lazyload alt=Page 17: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails17jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=18Page 18button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page18jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=18 data-page=18 class=ts-thumb lazyload alt=Page 18: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails18jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=19Page 19button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page19jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=19 data-page=19 class=ts-thumb lazyload alt=Page 19: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails19jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=20Page 20button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page20jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=20 data-page=20 class=ts-thumb lazyload alt=Page 20: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails20jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=21Page 21button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page21jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=21 data-page=21 class=ts-thumb lazyload alt=Page 21: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails21jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=22Page 22button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page22jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=22 data-page=22 class=ts-thumb lazyload alt=Page 22: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails22jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=23Page 23button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page23jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=23 data-page=23 class=ts-thumb lazyload alt=Page 23: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails23jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=24Page 24button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page24jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=24 data-page=24 class=ts-thumb lazyload alt=Page 24: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails24jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=25Page 25button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page25jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=25 data-page=25 class=ts-thumb lazyload alt=Page 25: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails25jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=26Page 26button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page26jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=26 data-page=26 class=ts-thumb lazyload alt=Page 26: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails26jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=27Page 27button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page27jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=27 data-page=27 class=ts-thumb lazyload alt=Page 27: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails27jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=28Page 28button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page28jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=28 data-page=28 class=ts-thumb lazyload alt=Page 28: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails28jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=29Page 29button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page29jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=29 data-page=29 class=ts-thumb lazyload alt=Page 29: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails29jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=30Page 30button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page30jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=30 data-page=30 class=ts-thumb lazyload alt=Page 30: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails30jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=31Page 31button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page31jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=31 data-page=31 class=ts-thumb lazyload alt=Page 31: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails31jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=32Page 32button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page32jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=32 data-page=32 class=ts-thumb lazyload alt=Page 32: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails32jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=33Page 33button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page33jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=33 data-page=33 class=ts-thumb lazyload alt=Page 33: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails33jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=34Page 34button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page34jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=34 data-page=34 class=ts-thumb lazyload alt=Page 34: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails34jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=35Page 35button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page35jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=35 data-page=35 class=ts-thumb lazyload alt=Page 35: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails35jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=36Page 36button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page36jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=36 data-page=36 class=ts-thumb lazyload alt=Page 36: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails36jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=37Page 37button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page37jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=37 data-page=37 class=ts-thumb lazyload alt=Page 37: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails37jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=38Page 38button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page38jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=38 data-page=38 class=ts-thumb lazyload alt=Page 38: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails38jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=39Page 39button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page39jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=39 data-page=39 class=ts-thumb lazyload alt=Page 39: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails39jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=40Page 40button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page40jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=40 data-page=40 class=ts-thumb lazyload alt=Page 40: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails40jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=41Page 41button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page41jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=41 data-page=41 class=ts-thumb lazyload alt=Page 41: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails41jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=42Page 42button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page42jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=42 data-page=42 class=ts-thumb lazyload alt=Page 42: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails42jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=43Page 43button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page43jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=43 data-page=43 class=ts-thumb lazyload alt=Page 43: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails43jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=44Page 44button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page44jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=44 data-page=44 class=ts-thumb lazyload alt=Page 44: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails44jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=45Page 45button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page45jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=45 data-page=45 class=ts-thumb lazyload alt=Page 45: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails45jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=46Page 46button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page46jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=46 data-page=46 class=ts-thumb lazyload alt=Page 46: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails46jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=47Page 47button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page47jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=47 data-page=47 class=ts-thumb lazyload alt=Page 47: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails47jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=48Page 48button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page48jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=48 data-page=48 class=ts-thumb lazyload alt=Page 48: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails48jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=49Page 49button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page49jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=49 data-page=49 class=ts-thumb lazyload alt=Page 49: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails49jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=50Page 50button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page50jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=50 data-page=50 class=ts-thumb lazyload alt=Page 50: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails50jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=51Page 51button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page51jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=51 data-page=51 class=ts-thumb lazyload alt=Page 51: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails51jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=52Page 52button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page52jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=52 data-page=52 class=ts-thumb lazyload alt=Page 52: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails52jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=53Page 53button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page53jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=53 data-page=53 class=ts-thumb lazyload alt=Page 53: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails53jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=54Page 54button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page54jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=54 data-page=54 class=ts-thumb lazyload alt=Page 54: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails54jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=55Page 55button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page55jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=55 data-page=55 class=ts-thumb lazyload alt=Page 55: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails55jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=56Page 56button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page56jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=56 data-page=56 class=ts-thumb lazyload alt=Page 56: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails56jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=57Page 57button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page57jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=57 data-page=57 class=ts-thumb lazyload alt=Page 57: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails57jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=58Page 58button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page58jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=58 data-page=58 class=ts-thumb lazyload alt=Page 58: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails58jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=59Page 59button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page59jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=59 data-page=59 class=ts-thumb lazyload alt=Page 59: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails59jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=60Page 60button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page60jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=60 data-page=60 class=ts-thumb lazyload alt=Page 60: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails60jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=61Page 61button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page61jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=61 data-page=61 class=ts-thumb lazyload alt=Page 61: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails61jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=62Page 62button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page62jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=62 data-page=62 class=ts-thumb lazyload alt=Page 62: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails62jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=63Page 63button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page63jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=63 data-page=63 class=ts-thumb lazyload alt=Page 63: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails63jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=64Page 64button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page64jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=64 data-page=64 class=ts-thumb lazyload alt=Page 64: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails64jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=65Page 65button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page65jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=65 data-page=65 class=ts-thumb lazyload alt=Page 65: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails65jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=66Page 66button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page66jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=66 data-page=66 class=ts-thumb lazyload alt=Page 66: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails66jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=67Page 67button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page67jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=67 data-page=67 class=ts-thumb lazyload alt=Page 67: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails67jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=68Page 68button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page68jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=68 data-page=68 class=ts-thumb lazyload alt=Page 68: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails68jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=69Page 69button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page69jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=69 data-page=69 class=ts-thumb lazyload alt=Page 69: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails69jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=70Page 70button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page70jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=70 data-page=70 class=ts-thumb lazyload alt=Page 70: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails70jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=71Page 71button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page71jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=71 data-page=71 class=ts-thumb lazyload alt=Page 71: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails71jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=72Page 72button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page72jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=72 data-page=72 class=ts-thumb lazyload alt=Page 72: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails72jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=73Page 73button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page73jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=73 data-page=73 class=ts-thumb lazyload alt=Page 73: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails73jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=74Page 74button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page74jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=74 data-page=74 class=ts-thumb lazyload alt=Page 74: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails74jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=75Page 75button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page75jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=75 data-page=75 class=ts-thumb lazyload alt=Page 75: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails75jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=76Page 76button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page76jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=76 data-page=76 class=ts-thumb lazyload alt=Page 76: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails76jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=77Page 77button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page77jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=77 data-page=77 class=ts-thumb lazyload alt=Page 77: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails77jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=78Page 78button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page78jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=78 data-page=78 class=ts-thumb lazyload alt=Page 78: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails78jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=79Page 79button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page79jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=79 data-page=79 class=ts-thumb lazyload alt=Page 79: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails79jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=80Page 80button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page80jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=80 data-page=80 class=ts-thumb lazyload alt=Page 80: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails80jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=81Page 81button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page81jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=81 data-page=81 class=ts-thumb lazyload alt=Page 81: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails81jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=82Page 82button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page82jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=82 data-page=82 class=ts-thumb lazyload alt=Page 82: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails82jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=83Page 83button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page83jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=83 data-page=83 class=ts-thumb lazyload alt=Page 83: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails83jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=84Page 84button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page84jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=84 data-page=84 class=ts-thumb lazyload alt=Page 84: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails84jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=85Page 85button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page85jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=85 data-page=85 class=ts-thumb lazyload alt=Page 85: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails85jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=86Page 86button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page86jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=86 data-page=86 class=ts-thumb lazyload alt=Page 86: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails86jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=87Page 87button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page87jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=87 data-page=87 class=ts-thumb lazyload alt=Page 87: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails87jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=88Page 88button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page88jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=88 data-page=88 class=ts-thumb lazyload alt=Page 88: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails88jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=89Page 89button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page89jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=89 data-page=89 class=ts-thumb lazyload alt=Page 89: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails89jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=90Page 90button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page90jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=90 data-page=90 class=ts-thumb lazyload alt=Page 90: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails90jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=91Page 91button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page91jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=91 data-page=91 class=ts-thumb lazyload alt=Page 91: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails91jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=92Page 92button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page92jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=92 data-page=92 class=ts-thumb lazyload alt=Page 92: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails92jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=93Page 93button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page93jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=93 data-page=93 class=ts-thumb lazyload alt=Page 93: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails93jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=94Page 94button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page94jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=94 data-page=94 class=ts-thumb lazyload alt=Page 94: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails94jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=95Page 95button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page95jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=95 data-page=95 class=ts-thumb lazyload alt=Page 95: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails95jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=96Page 96button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page96jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=96 data-page=96 class=ts-thumb lazyload alt=Page 96: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails96jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=97Page 97button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page97jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=97 data-page=97 class=ts-thumb lazyload alt=Page 97: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails97jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=98Page 98button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page98jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=98 data-page=98 class=ts-thumb lazyload alt=Page 98: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails98jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=99Page 99button div class=ts-imagea href=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5page99jpg target=_blank img data-url=espanola-de-investigacion-y-del-metabolismo-mineral-2014-factores-restrictiwshtmlpage=99 data-page=99 class=ts-thumb lazyload alt=Page 99: Española de Investigación y del Metabolismo Mineral 2014 Factores restrictiws para via oral AD - Polimedicación Comorbibdad Raloxifene Evista Ibandronate Boniva Alendronate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader042vdocumentsusreader042viewer20220228005c6e0b7709d3f274098c5fe0html5thumbnails99jpg width=140 height=200 adivdiv
